Sanofi and GSK signed agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
On Sept. 22, 2020, Sanofi and GSK announced they had signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021.
Tags:
Source: GlaxoSmithKline
Credit:
